The Ad5 vector-based COVID-19 vaccine, Ad5-nCoV, encodes a full-length mammalian-cell-optimized S protein with a tissue plasminogen activator (tPA) signal peptide; this vaccine was developed by CanSino and has been approved in China [33]. This evidence concerns the gene PLAT and COVID-19.